Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (21-30 of 323) with videos related to

Pageof 33
Sort By:
Advances in Therapy|June 2, 2016
An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate CancerAxel S Merseburger, Marie C Hupe
Aktuelle Urologie|March 20, 2020
[Current data on the target value of testosterone lowering and the associated research since the first administration of LHRH (GnRH) analogues to patients 40 years ago]Peter Hammerer, Walther Grohmann, Axel S Merseburger
World Journal of Urology|September 24, 2013
Gender in urologyAxel S Merseburger, Franziska Gätcke, Mesut Remzi
Aktuelle Urologie|September 6, 2019
[Current recommendations for the systemic treatment of metastatic renal cell carcinoma]Nils Kröger, Axel S Merseburger, Jens Bedke
European Urology|May 15, 2024
Therapy Optimization in the Management of Metastatic Hormone-sensitive Prostate Cancer: Insights from the ARASENS StudyAxel S Merseburger, Simon Chowdhury, Amit Bahl
Current Opinion in Urology|October 24, 2017
Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutritionRana Tahbaz, Marianne Schmid, Axel S Merseburger
World Journal of Urology|September 26, 2015
Comment on: "Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years"Christoph-A von Klot, Axel S Merseburger
Aktuelle Urologie|September 6, 2018
[Symptomatic renal tumours in metastatic renal cell carcinoma - surgical options]Nils Gilbert, Axel S Merseburger, Mario Kramer
European Urology Focus|August 6, 2024
Targeting Androgen Receptor Alterations in Metastatic Prostate CancerPawel Rajwa, Piotr Zapała, Axel S Merseburger
World Journal of Urology|May 12, 2010
Management of sunitinib-related adverse events: an evidence- and expert-based consensus approachViktor Grünwald, Daniel Kalanovic, Axel S Merseburger
Pageof 33

Showing results (21-30 of 323) with videos related to

Sort By:
Pageof 33
Advances in Therapy|June 2, 2016
An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate CancerAxel S Merseburger, Marie C Hupe
Aktuelle Urologie|March 20, 2020
[Current data on the target value of testosterone lowering and the associated research since the first administration of LHRH (GnRH) analogues to patients 40 years ago]Peter Hammerer, Walther Grohmann, Axel S Merseburger
World Journal of Urology|September 24, 2013
Gender in urologyAxel S Merseburger, Franziska Gätcke, Mesut Remzi
Aktuelle Urologie|September 6, 2019
[Current recommendations for the systemic treatment of metastatic renal cell carcinoma]Nils Kröger, Axel S Merseburger, Jens Bedke
European Urology|May 15, 2024
Therapy Optimization in the Management of Metastatic Hormone-sensitive Prostate Cancer: Insights from the ARASENS StudyAxel S Merseburger, Simon Chowdhury, Amit Bahl
Current Opinion in Urology|October 24, 2017
Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutritionRana Tahbaz, Marianne Schmid, Axel S Merseburger
World Journal of Urology|September 26, 2015
Comment on: "Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years"Christoph-A von Klot, Axel S Merseburger
Aktuelle Urologie|September 6, 2018
[Symptomatic renal tumours in metastatic renal cell carcinoma - surgical options]Nils Gilbert, Axel S Merseburger, Mario Kramer
European Urology Focus|August 6, 2024
Targeting Androgen Receptor Alterations in Metastatic Prostate CancerPawel Rajwa, Piotr Zapała, Axel S Merseburger
World Journal of Urology|May 12, 2010
Management of sunitinib-related adverse events: an evidence- and expert-based consensus approachViktor Grünwald, Daniel Kalanovic, Axel S Merseburger
Pageof 33